Wednesday, June 11 2008
Asthma Inhaler Warnings
Salmeterol, marketed and manufactured by GlaxoSmithKline,(GSK) in the 1980s and was released as Serevent in 1990. However, the product is under license from Allen & Hanburys.(UK) GSK also markets the asthma inhaler called Advair. GSK's Advair and Serevent have been the subject of many asthma related death claims in the past few years. Read more at: Advair Inhaler Death Lawsuits
In November of 2005, the American FDA released a health warning alerting asthma inhaler users with Salmeterol to findings that show the use of Long-acting â2-agonists could lead to a worsening of symptoms, and in some cases death. See more details about medical studies about increased risks of Advair & Servevent asthma inhaler deaths
Friday, June 06 2008
Iloprost / Ventavis Warning
The FDA has announced a partial recall of Ventavis / Iloprost, a drug marketed by Actelion Pharmaceuticals US, Inc. for the treatment of Pulmonary Arterial Hypertension (PAH), or Primary Pulmonary Hypertension (PPH). The Iloprost Ventavis recall was announced after Actelion received numerous reports that some ampules of Iloprost Ventavis were empty or contained less than the full amount of Vantavis.
Defective Iloprost / Ventavis Recalled by FDA
This manufacturing defect of Ventavis / Iloprost can result in a person with PAH or PPH receiving too little medication, which can be potentially fatal. The recalled lots of Ventavis/iloprost are Lots #63228A, #63230A, #63231A and #63232A. Ventavis / Iloprost is an inhalation solution that comes in glass ampules.The incorrect amount of Ventavis / iloprost can cause serious personal injury or death to a PPH or PAH patient.